Perspective for the treatment of diabetic neuropathy: Translation from molecular studies to bedside

Clinical Neurology

Volumn 45, Issue 11, 2005, Pages 966-968

  Yagihashi, Soroku ^a   Yamagishi, Shin Ichiro ^a   Wada, Ryuichi ^a  

^a HIROSAKI UNIVERSITY   (Japan)

Author keywords

Diabetic neuropathy; Glycation; Molecular mechanisms; Oxidative stress; Polyol pathway

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); PROTEIN KINASE C;

CONFERENCE PAPER; DIABETIC NEUROPATHY; DIABETIC PATIENT; ENZYME ACTIVITY; GLYCATION; HUMAN; HYPERGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; METABOLIC REGULATION; PERIPHERAL NERVE; PERIPHERAL NEUROPATHY; POSTPRANDIAL STATE; PRIMARY PREVENTION; TISSUE SPECIFICITY;

ALDEHYDE REDUCTASE; ANIMALS; DIABETIC NEUROPATHIES; HYPERGLYCEMIA; MICE; NA(+)-K(+)-EXCHANGING ATPASE; OXIDATIVE STRESS; PERIPHERAL NERVES; POLYMERS; PROTEIN KINASE C;

EID: 31544458157     PISSN: 0009918X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (10)

1. Malik RA, Tesfaye S, Newrick PG, et al: Sural nerve pathology in diabetic patients with minimal but progressive neuropathy. Diabetologia 2005; 48: 578-585
2. Sumner CJ, Sheth S, Griffin JW, et al: The spectrum of neuropathy in diabetes and impaired glucose tolerance. Neurology 2003; 60: 108-111
3. Kitahara Y, Miura K, Takesue K, et al: Decreased blood glucose excursion by nateglinide ameliorated neuropathic changes in Goto-Kakizaki rats, an animal model of non-obese type 2 diabetes. Metabolism 2002; 51: 1452-1457
4. Yagihashi S, Yamagishi S, Wada R, et al: Galactosemic neuropathy in transgenic mice for human aldose reductase. Diabetes 1996; 45: 56-59
5. Yagihashi S, Yamagishi SI, Wada R, et al: Neuropathy in diabetic mice overexpressing human aldose reductase and effects of aldose reductase inhibitor. Brain 2001; 124: 2448-2458
6. Yamagishi S, Uehara K, Otsuki S, et al: Differential influence of increased polyol pathway on protein kinase C expressions between endoneurial and epineurial tissues in diabetic mice. J Neurochem 2003; 87: 497-507
7. Chung SK, Ho ECM, Lam KSL, et al: Implications of the aldose reductase gene in peripheral nerve integrity and its environmental insults in diabetes. J PNS 2003; 8: 169 (Abstract of Neurodiab in St Malo, 2003)
8. Wada R, Nishizawa Y, Yagihashi N, et al: Effects of OPB-9195, anti-glycation agent, on experimental diabetic neuropathy. Eur J Clin Invest 2001; 31: 513-520
9. Bierhaus A, Haslbeck KM, Humpert PM, et al: Loss of pain perception in diabetes is dependent on a receptor of the immunoglobulin superfamily. J Clin Invest 2004; 114: 1741-1751
10. Wada R, Yagihashi S: Role of advanced glycation end products and their receptors in development of diabetic neuropathy. Ann NY Acad Sci 2005; 1043: 598-604